Background: PET and SPECT imaging methods can be of excellent assistance for the
development of new nanoparticle drug delivery systems, and at the same time, these …

Breast cancer is the most frequent cancer in women and it is the main reason of cancer-
related deaths of women worldwide. Different types of breast cancer diagnostic …

Non-small cell lung carcinoma (NSCLC) is among the most lethal lung cancers responsible
for 80–85% of death. α v β 3 integrin receptor subtype has been identified as a lung cancer …

The high incidence and mortality of breast cancer supports efforts to develop innovative
imaging probes to effectively diagnose, evaluate the extent of the tumor, and predict the …

Objective Early diagnosis of malignant tumors is essential to successfully plan a radical and
curative approach. In this study we describe the direct radiolabeling of doxorubicin (DOX) at …

Abstract The [99m Tc] Tc-Doxorubicin–Gold Nanoparticles (99m Tc-Dox-AuNPs) was
formulated as a nanoradiopharmaceutical by different loading procedures to enhance tumor …

Some of the issues regarding introducing new radiocompounds in nuclear medicine are the
distribution patterns, delivered dose to different organs, diagnostic abilities and side effects …

The present study describes the successful radiolabeling of [99mTcO− 4] with doxorubicin,
and the resultant product was formulated in to a ready‐to‐label lyophilized single vial kit …

Objective: Doxorubicin (Eurofarma, São Paulo, Brazil) is an antitumour agent widely used in
the treatment of breast cancer and can be used for tumour tracking when labelled with a …

Introduction: Diethylenetriaminepentaacetic acid (DTPA) is a chelating agent used as a
radiopharmaceutical compound, 99mTc-DTPA, for renography. Doxorubicin (DOX) on the …